Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

News Daily News

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

December 23, 2020

CAC Testing Improves Pretest Probability of Obstructive CAD

News Daily News

CAC Testing Improves Pretest Probability of Obstructive CAD

Michael O'Riordan

November 23, 2020

Statin Benefits Confirmed in Elderly, Along With Harmful Effects of High Cholesterol

News Conference News AHA 2020

Statin Benefits Confirmed in Elderly, Along With Harmful Effects of High Cholesterol

Michael O'Riordan

November 12, 2020

High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention

News Daily News

High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention

Michael O'Riordan

August 11, 2020

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

News Daily News

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Michael O'Riordan

August 06, 2020

Cholesterol Guidelines Fail Young MI Patients Who Might Have Benefited From Statins

News Daily News

Cholesterol Guidelines Fail Young MI Patients Who Might Have Benefited From Statins

August 04, 2020

Which Modality and When? New Guidance for Cardiac Imaging in COVID-19

News Daily News

Which Modality and When? New Guidance for Cardiac Imaging in COVID-19

July 24, 2020

Biggest Barriers to Cardiac CT? Old Myths, Fair Payment, and De-adoption

News Conference News SCCT 2020

Biggest Barriers to Cardiac CT? Old Myths, Fair Payment, and De-adoption

Yael L. Maxwell

July 22, 2020

Race and Gender Bias May Sway Decisions in Advanced HF Care

News Daily News

Race and Gender Bias May Sway Decisions in Advanced HF Care

July 21, 2020

As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI

News

As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI

Michael O'Riordan

April 17, 2020

Pricey, Unproven ‘Executive’ CVD Screening the Norm at Top US Hospitals

News Daily News

Pricey, Unproven ‘Executive’ CVD Screening the Norm at Top US Hospitals

Michael O'Riordan

January 16, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.